Characterized by isolated, circular aneurysmal lesions surrounding the fovea centralis.
Target Population
Otherwise healthy patients, specifically noted in a 44-year-old Chinese woman.
Care Setting
Outpatient clinic
Key Highlights
PEVAC can lead to secondary fundus hemorrhage.
Diagnosis confirmed through multiple imaging modalities including FFA, ICGA, OCT, and OCTA.
Intravitreal anti-VEGF treatment resulted in marked improvement in visual acuity.
Menstrual cycle may influence disease progression, though the relationship is unclear.
Guideline-Based Recommendations
Diagnosis
Use fundus fluorescein angiography, indocyanine green angiography, optical coherence tomography, and optical coherence tomography angiography for diagnosis.
Management
Intravitreal anti-VEGF therapy is recommended for treatment.
Monitoring & Follow-up
Regular follow-up to assess visual acuity and changes in retinal lesions.
Risks
Laser photocoagulation poses a risk of iatrogenic foveal damage.
Patient & Prescribing Data
A 44-year-old Chinese woman with no significant past medical history.
Intravitreal ranibizumab injections were administered, leading to improvement in visual acuity.
Clinical Best Practices
Consider the potential influence of the menstrual cycle on visual acuity in female patients.
Prioritize non-invasive treatment options when lesions are near the fovea.
